Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
New study finds cellular immunotherapy treatment associated with improved quality of life
Adult lymphoma patients whose disease was effectively treated with chimeric antigen receptor T-cell (CAR-T) therapy…
First baby born to cancer patient from eggs matured in the lab and frozen
Fertility doctors in France have announced the birth of the first baby to be born…
Test measures immune response to improve ovarian cancer diagnosis
Researchers have developed a simple blood test that measures the body’s own immune response to…
War metaphors for cancer hurt certain prevention behaviours
It’s not unusual for people to use war metaphors such as “fight” and “battle” when trying to motivate patients with…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.